Summary
Purified pancreatic Beta cells were labelled with 3H-tyrosine before studying their secretory activity in perifusion. At 1.4 mmol/l glucose, the cells released similar fractions (0.01% per min) of their contents in preformed and in newly formed insulin. At 20 mmol/l glucose plus 10−8 mol/l glucagon, these fractional release rates increased by 16 and 40-fold respectively. The preferential release of newly synthesized as compared to stored insulin is attributable to a heterogeneity in individual cell responses. The secretory responsiveness to glucose plus glucagon was completely suppressed by 10−7 mol/l clonidine. Insulin induced a 20% reduction at 10−6 mol/l, but remained without effect at 10−7 mol/l. Insulin-like growth factor-I provoked a 30% decrease at 5.10−9 mol/l. It is concluded that the type-I insulin-like growth factor receptors on pancreatic Beta cells mediate a suppressive action on the insulin release process. Their high affinity for insulin-like growth factor-I allows physiologic levels of this peptide to participate in the regulation of insulin release. Their low affinity for insulin provides the basis for a minor feedback action by this hormone at concentrations exceeding the normal circulating levels.
Article PDF
Similar content being viewed by others
References
Sodoyez JC, Sodoyez-Goffeaux F, Foà PP (1969) Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans. Proc Soc Exp Biol Med 1699: 568–571
Iversen J, Miles DW (1971) Evidence for a feedback inhibition of insulin on insulin secretion in the isolated perfused canine pancreas. Diabetes 20: 1–9
Rappaport AM, Ohira S, Coddling JA, Empey G, Kalnins A, Lin BJ, Haist RE (1972) Effects on insulin output and on pancreatic blood flow of exogenous insulin infusion into an in situ isolated portion of the pancreas. Endocrinology 91: 168–176
Loreti L, Dunbar JC, Chen S, Foà PP (1974) The autoregulation of insulin secretion in the isolated pancreatic islets of lean (obOb) and obese-hyperglycemic (obob) mice. Diabetologia 10: 309–315
Ammon HPT, Verspohl E (1976) Pyridine nucleotides in pancreatic islets during inhibition of insulin release by exogenous insulin. Endocrinology 99: 1469–1476
Liljenquist JE, Horwitz DL, Jennings AS, Chiasson JL, Keller U, Rubenstein AH (1978) Inhibition of insulin secretion by exogenous insulin in normal man as demonstrated by C-peptide assay. Diabetes 27: 563–570
Service FJ, Nelson RL, Rubenstein AH, Go VLW (1978) Direct effect of insulin on secretion of insulin, glucagon, gastric inhibtory polypeptide and gastrin during maintenance of normoglycemia. J Clin Endocrin Metab 47: 488–493
De Fronzo RA, Binder C, Wahren J, Felig P, Ferrannini E, Faber OK (1981) Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. Acta Endocrinol 98: 81–86
Waldhäusl WK, Casic S, Bratusch-Marrain P, Korn A, Nowotny P (1982) Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects. Am J Physiol: E476–E482
Draznin B, Goodman M, Leitner JW, Sussman KE (1986) Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets. Endocrinology 118: 1054–1058
Argoud GM, Schade DS, Eaton RP (1987) Insulin suppresses its own secretion in vivo. Diabetes 36: 959–962
Malaisse WJ, Malaisse-Lagae F, Lacy PE, Wright PH (1967) Insulin secretion by isolated islets in the presence of glucose, insulin and anti-insulin serum. Proc Soc Exp Biol Med 124: 497–500
Schatz H, Pfeiffer EF (1977) Release of immunoreactive and radioactively prelabelled endogenous (pro-)insulin from isolated islets of rat pancreas in the presence of exogenous insulin. J Endocrinol 74: 243–249
Marincola F, Frank W, Clark W, Douglas M, Merrell R (1983) The independence of insulin release and ambient insulin in vitro. Diabetes 32: 1162–1167
Stagner JI, Samols E, Polonski K, Pugh W (1986) Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas. J Clin Invest 78: 1193–1198
Pipeleers DG, In't Veld PA, Van De Winkel M, Maes E, Schuit FC, Gepts W (1985) A new in vitro model for the study of pancreatic A-and B-cells. Endocrinology 117: 806–816
Pipeleers DG, Pipeleers-Marichal MA (1981) A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 20: 654–663
Pipeleers DG, In't Veld PA, Maes E, Van De Winkel M (1982) Glucose-induced insulin release depends on functional cooperation between islet cells. Proc Natl Acad Sci USA 79: 7322–7325
Schuit FC, In't Veld PA, Pipeleers DG (1988) Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci USA 85: 3865–3869
Pipeleers DG, Schuit FC, In't Veld PA, Maes E, HooghePeters EL, Van de Winkel M, Gepts W (1985) Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117: 824–833
Schuit FC, Pipeleers DG (1986) Differences in adrenergic recognition by pancreatic A-and B-cells. Science 232: 875–877
Sando H, Grodsky GM (1973) Dynamic synthesis and release of insulin and proinsulin from perifused islets. Diabetes 22: 354–360
Rhodes CJ, Halban PA (1987) Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J Cell Biol 105: 145–153
Pipeleers DG (1987) The biosociology of pancreatic B cells. Diabetologia 30: 277–291
Van Schravendijk CFH, Foriers A, Van den Brande JL, Pipleers DG (1987) Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121: 1784–1788
Conover CA, Hintz RL, Rosenfeld RG (1985) Comparative effects of somatomedin C and insulin on the metabolism and growth of cultured human fibroblasts. J Cell Physiol 122: 133–141
Flier JS, Usher P, Moses AC (1986) Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83: 664–668
Van Wyk JJ, Graves DC, Casella SJ, Jacobs S (1985) Evidence from monoclonal antibody studies that insulin stimulates desoxyribonucleic acid synthesis through the type-I somatomedin receptor. J Clin Endocrinol Metab 61: 639–644
Froesch ER, Zapf J (1985) Insulin-like growth factors and insulin: comparative aspects. Diabetologia 28: 485–493
Ceda GP, Davis RG, Rosenfeld RG, Hoffman AR (1987) The growth hormone (GH)-releasing hormone (GHRH)-GH-Somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 120: 1658–1662
Guler HP, Schmid C, Zapf J, Froesch ER (1989) Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86: 2868–2872
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Schravendijk, C.F.H., Heylen, L., Van den Brande, J.L. et al. Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia 33, 649–653 (1990). https://doi.org/10.1007/BF00400565
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400565